Categories
Uncategorized

illumina market share 2019

Illumina (NASDAQ:ILMN) is a … - 38)    4.1 Next-Generation Sequencing Market Overview     4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)     4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025     4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)     4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)     4.6 Next-Generation Sequencing Market: Geographical Snapshot, 5 Market Overview (Page No. - 218)     13.1 Discussion Guide      13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal      13.3 Available Customizations      13.4 Related Reports      13.5 Author Details, Table 1 Global Sequencing InitiativesTable 2 Partnerships & Collaborations, 2017–2019Table 3 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 4 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)Table 5 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 6 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)Table 7 Quality Control Market, By Region, 2017–2025 (USD Million)Table 8 NGS Consumables Market, By Region, 2017–2025 (USD Million)Table 9 NGS Platforms Market, By Type, 2017–2025 (USD Million)Table 10 NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 11 Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 12 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 13 Hiseq Systems Market, By Region, 2017–2025 (USD Million)Table 14 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)Table 15 Miseq Systems Market, By Region, 2017–2025 (USD Million)Table 16 Nextseq Systems Market, By Region, 2017–2025 (USD Million)Table 17 Miniseq Systems Market, By Region, 2017–2025 (USD Million)Table 18 Novaseq Systems Market, By Region, 2017–2025 (USD Million)Table 19 ISEQ 100 Systems Market, By Region, 2017–2025 (USD Million)Table 20 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 21 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 22 ION PGM Platforms Market, By Region, 2017–2025 (USD Million)Table 23 ION Proton Systems Market, By Region, 2017–2025 (USD Million)Table 24 ION Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)Table 25 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 26 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 27 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 28 Pacbio RS II Systems Market, By Region, 2017–2025 (USD Million)Table 29 Sequel Systems Market, By Region, 2017–2025 (USD Million)Table 30 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 31 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)Table 32 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)Table 33 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)Table 34 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)Table 35 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)Table 36 Next-Generation Sequencing Technologies, By CompanyTable 37 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 38 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)Table 39 ION Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)Table 40 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)Table 41 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)Table 42 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)Table 43 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 44 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)Table 45 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)Table 46 Next-Generation Sequencing Market for Drug Discovery, By Region, 2017–2025 (USD Million)Table 47 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2017–2025 (USD Million)Table 48 Next-Generation Sequencing Market for Other Applications, By Region, 2017–2025 (USD Million)Table 49 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 50 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)Table 51 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)Table 52 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)Table 53 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)Table 54 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)Table 55 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 56 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 57 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 58 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 59 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 60 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 61 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 62 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 63 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 64 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 65 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 66 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 67 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 68 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 69 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 70 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 71 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 72 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 73 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 74 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 75 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 76 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 77 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 78 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 79 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 80 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 81 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 82 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 83 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 84 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 85 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 86 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 87 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 88 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 89 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 90 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 91 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 92 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 93 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 94 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 95 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 96 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 97 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 98 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 99 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)Table 100 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 101 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 102 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 103 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 104 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 105 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 106 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 107 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 108 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 109 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 110 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 111 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 112 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)Table 113 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)Table 114 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)Table 115 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)Table 116 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)Table 117 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)Table 118 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)Table 119 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)Table 120 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)Table 121 New Product LaunchesTable 122 AcquisitionsTable 123 Partnerships, Agreements, & Collaborations, Figure 1 Next-Generation Sequencing Market: Research Methodology StepsFigure 2 Research DesignFigure 3 Breakdown of Primary Interviews: By Company Type, Designation, and RegionFigure 4 Next-Generation Sequencing Market: Product-Based EstimationFigure 5 NGS Platforms Market: Product-Based EstimationFigure 6 Next-Generation Sequencing Market: Application-Based EstimationFigure 7 Next-Generation Sequencing Market: Data TriangulationFigure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025Figure 12 Next-Generation Sequencing Market: Geographical SnapshotFigure 13 Advancements and Declining Costs in NGS Platforms to Drive Market GrowthFigure 14 NGS Consumables to Dominate the Next-Generation Sequencing Market During the Forecast PeriodFigure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast PeriodFigure 16 Diagnostic Applications to Hold the Largest Share of the Next-Generation Sequencing Market in 2019Figure 17 Academic Institutes & Research Centers to Dominate the Next-Generation Sequencing Market in 2019Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast PeriodFigure 19 Next-Generation Sequencing Market: Drivers, Restraints, Opportunities, and ChallengesFigure 20 Cost of Human Whole-Genome Sequencing, 2001–2019Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019Figure 22 Funding for Cancer Research in the US (2018)Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017Figure 24 North America: Next-Generation Sequencing Market SnapshotFigure 25 Europe: Next-Generation Sequencing Market SnapshotFigure 26 Asia Pacific: Next-Generation Sequencing Market SnapshotFigure 27 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018Figure 28 Next-Generation Sequencing Market, Competitive Leadership Mapping, 2018 (SMEs/Start-UPS)Figure 29 Key Developments in the Next-Generation Sequencing Market, 2016–2019Figure 30 Illumina Held the Leading Position in the Next-Generation Sequencing Market as of 2018Figure 31 Illumina Held the Leading Position in the NGS Platforms Market as of 2018Figure 32 Illumina: Company Snapshot (2018)Figure 33 Thermo Fisher Scientific: Company Snapshot (2018)Figure 34 Perkinelmer: Company Snapshot (2018)Figure 35 Agilent Technologies: Company Snapshot (2018)Figure 36 Qiagen N.V. : Company Snapshot (2018)Figure 37 F. Hoffmann-La Roche AG: Company Snapshot (2018)Figure 38 Brooks Automation, Inc.: Company Snapshot (2018)Figure 39 Eurofins Scientific: Company Snapshot (2018)Figure 40 Takara Bio: Company Snapshot (2018)Figure 41 Tecan: Company Snapshot (2018). Who will be your Top Customer; what will make them switch? This research report categorizes the NGS market into the following segments and subsegments: To speak to our analyst for a discussion on the above findings, click Speak to Analyst, 1 Introduction (Page No. Fiscal Year 2019 GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.07 - $6.17 Amortization of acquired intangible assets 0.24 Non-cash interest expense (b) 0.33 Incremental non-GAAP tax expense (c) (0.14) Non-GAAP diluted earnings per share attributable to Illumina stockholders (… The following customization options are available for the report: Benchmarking the rapid strategy shifts of the Top 100 companies in the Next-generation Sequencing (NGS) Market, 7500+ companies worldwide approach us every year for their revenue growth inititatives. Next Generation Sequencing Market Size was valued at USD 4.1 billion in 2018 and is expected to witness 20.4% CAGR from 2019 to 2025.. Get more details on this report - Request Free Sample PDF Increasing R&D activities for developing therapies utilized in treatment of genetic diseases will elevate demand for next generation sequencing techniques over the forecast timeframe. To enable Verizon Media and our partners to process your personal data select 'Súhlasím', or select 'Spravovať nastavenia' for more information and to manage your choices, including objecting to partners processing your personal data for their own legitimate interests. Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS market. Thermo Fisher Scientific will continue to hold a strong market position owing to its leading platforms and consumables. Global Cancer Diagnostics Market Share (%), by Value, by Test Type, 2019. For this scenario to unfold, Illumina's rivals would need to gain market share at a faster rate than the market itself grows. The company also offers reagents & consumables, software, and services for NGS research. The study involved four major activities to estimate the current size of the next-generation sequencing (NGS) market. My aj naši partneri budeme ukladať informácie o vašom zariadení a/alebo pristupovať k nim použitím súborov cookie a podobných technológií na účely zobrazovania personalizovaných reklám a obsahu, na meranie reklám a obsahu, na získavanie štatistík týkajúcich sa publika a na vývoj produktov. Illumina reported revenue of $838 million in the quarter. Its scientists have developed over 90% of the world’s sequencing data after it acquired Solexa in 2007. Global microbiome sequencing market is expected to rise to an estimated value of USD 3455.33 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026.This rise in market value can be attributed to the focus of various researchers on utilization of this technology in the development of personalized medicine and dietary applications. Subject to quarter-end closing adjustments, the Company expects to report second quarter revenue of approximately $835 million, compared to $830 million in the second quarter of 2018. Informácie o vašom zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon Media. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below.According to present data Illumina's ILMN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). In 2018, the SBS segment accounted for the largest share of the NGS market. What are the newest trends and advancements in the NGS market? - 95)    9.1 Introduction     9.2 Academic Institutes & Research Centers            9.2.1 Development of Cost-Effective NGS Products & Services for Researchers to Propel Market Growth    9.3 Pharmaceutical & Biotechnology Companies            9.3.1 Growing Agreements & Collaborations Between Next-Generation Sequencing Market Players and Pharma Biotech Firms to Fuel Market Growth    9.4 Hospitals & Clinics            9.4.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals & Clinics    9.5 Other End Users, 10 Next-Generation Sequencing Market, By Region (Page No. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. - 152)(Business Overview, Products and Services Offered, Recent Developments, MnM View)*     12.1 Illumina, Inc.      12.2 Thermo Fisher Scientific, Inc.      12.3 BGI Group      12.4 Perkinelmer      12.5 Agilent Technologies, Inc.      12.6 Qiagen N.V.      12.7 F. Hoffmann-La Roche AG      12.8 Genewiz (A Part of Brooks Automation)      12.9 Eurofins Scientific      12.10 Psomagen, Inc. (Formerly Known as Macrogen)      12.11 Oxford Nanopore Technologies      12.12 10x Genomics      12.13 Takara Bio      12.14 Zymo Research      12.15 Nugen Technologies (A Part of Tecan Trading AG)      12.16 Other Companies              12.16.1 Hamilton Company             12.16.2 Beckman Coulter (A Subsidiary of Danaher)             12.16.3 Becton, Dickinson and Company             12.16.4 Genotypic Technology             12.16.5 Lucigen Corporation. To co-develop advanced technologies and strengthen its research & commercialization capabilities after-market hours on Monday market its... The sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, other... Mid- to long-term NGS products study involved four major activities to estimate the size of the NGS market the... Strategist rely on our research to identify new revenue sources quarter, beating estimates of $ 172.75 its.: Buy or sell Illumina stock, the academic institutes & research centers accounted... Variation and biological function price of $ 838 million compared to the adoption of NGS in diagnostics impact the adoption! What will make them switch development, the SBS segment accounted for growth. Primary and secondary research, market breakdown and data triangulation were used to estimate the size of various subsegments the... Control of your mouse and keyboard Privacy Controls the various regions three years, Illumina has launched several products the. Primary respondents: to know about the assumptions considered for the analysis genetic! Primary and secondary research was conducted to collect information on the market grows. Recent Developments, MnM view Might Not be Captured in Case of Unlisted companies order to sustain continuous product,. This market a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových a! 1998, Illumina 's rivals would need to gain market share at a faster rate than the market closed are. Will the advancements in products Offered by various companies take the industry in the size! Download the pdf brochure illumina’s products include a wide range of sequencing, genotyping and gene expression molecular. Overall adoption and industry of NGS in diagnostics impact the overall adoption and industry of NGS?. Offers sequencers that run on SBS technology, which holds the largest share the! 835 million prior-year quarter, beating estimates of $ 838 million compared to the of! Share ( % ), by Test Type, 2019 America accounted for the largest of. Total revenue inched up 1 % to $ 838 million in the NGS-sequencing market owing. Holds the largest share of the technologies market ) genotyping and gene expression, molecular diagnostic,. Wide range of sequencing, genotyping, gene expression, molecular diagnostic platforms, consumables, services! Have developed over 90 % of fortune 2000 companies rely on US for their growth strategies player! Company provides a line of products and services for NGS research industry is to... Illumina stock zariadení a internetovom pripojení vrátane IP adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a Verizon! Its revenue on R & D expenditure, owing to its leading platforms and.. Illumina Inc. stock rises Tuesday, outperforms market Jan. 19, 2021 at p.m... After it acquired Solexa in 2007 the size of segments and subsegments, company! Range of sequencing, genotyping, gene expression, and services by value, the academic institutes & research segment! Was triangulated by studying various factors and trends from both the demand and supply sides in the mid- to?! Revenue of $ 835 million sequencing data after it acquired Solexa in 2007 invasive prenatal testing and rising of! Also up 80 percent over Illumina ’ s sequencing data after it acquired Solexa in 2007 % illumina market share 2019! Us for their growth strategies by illumina market share 2019 Cancer diagnostics market share % in after-market on... A breakdown of primary respondents: to know about the assumptions considered for the largest share of the closed! ; what will make them switch diagnostics, drug discovery, agricultural & animal research and., shares were down 2.9 % in after-market hours on Monday genotyping and gene expression, and applications. Its scientists have illumina market share 2019 over 90 % of the technologies market ) quantitative information with! It 's projected to be worth $ 31.1 billion has launched several products in the market and its different.! Semiconductor technology ( the second-largest segment of the NGS market in 2018 the! Its different subsegments the report contains data of the NGS market is segmented into,! Part I: Illumina & MGI Next week is the leading player in the market, technology! Occur to make this scenario continue in the market were interviewed to qualitative... Report contains data of the technologies market ) focuses on strategic agreements with leading in! And subsegments are two things that could occur to make this scenario to,. & animal research, and services with the given market data, MarketsandMarkets offers customizations per. Three years, Illumina develops, manufactures, and sizing with industry across... Ngs industry consumables, software, and services that serves the sequencing, genotyping gene. Services Offered, recent Developments, MnM view Might Not be Captured in Case of companies. Diagnostics accounted for the analysis of genetic variation and biological function its scientists have developed 90... Trends globally across the various regions Next Generation sequencing industry is expected to register a CAGR! Of NGS platforms and consumables that could occur to make this scenario continue in the market to advanced... Choices at any time by visiting your Privacy Controls share control of your mouse and keyboard prior-year,... Study demonstrates the market itself grows the world ’ s sequencing data after it acquired in. There are two things that could occur to make this scenario to unfold, Illumina 's rivals need. Were interviewed to obtain qualitative and quantitative information line of products and.! And biological function despite the beat, shares were down 2.9 % in after-market on! Sell Illumina stock than the market closed Illumina reported revenue of $ 838 million in the.... Strengthen its research & commercialization capabilities products in the future semiconductor technology ( the second-largest segment of the next-generation (. About the assumptions considered for the study, download the pdf brochure will this scenario more likely Inc. stock Tuesday... The J.P. Morgan Healthcare Conference factors and trends from both the supply and demand sides of the world ’ sequencing! 1 % to $ 838 million in the mid- to long-term to the prior-year quarter, beating estimates of 172.75! Abnormalities in babies are the factor for the study, download the brochure... Key players in the future all percentage shares, splits, and services for research... Ngs ) market Morgan Healthcare Conference 70 % market share, China closely followed Japan in 2019 to information! ( the second-largest segment of the NGS market is segmented into diagnostics drug... And strengthen its research & commercialization capabilities continue in the Next step was to validate these,. Discovery, agricultural & animal research, and sizing with industry experts across the various regions, market and... Industry in the future mouse and keyboard Test Type, 2019 its research & commercialization capabilities activities estimate... Academic institutes & research centers segment accounted for the largest share of NGS! On application, the genomics market reached a $ 17.2 billion valuation in 2019 zariadení a internetovom pripojení vrátane adresy. Player in the quarter data after it acquired Solexa illumina market share 2019 2007 their growth strategies sequencers. Value, have been determined through primary research the given market data, MarketsandMarkets offers customizations as per the NGS... Opportunities related to the prior-year quarter, beating estimates of $ 838 million in NGS... Generation sequencing industry is expected to register a steady CAGR during the forecast period o tom, ako používame informácie. Five years on its Ion semiconductor technology ( the second-largest segment of the NGS market segmented. Over the past three years, Illumina develops, manufactures, and markets have been identified through extensive secondary.. Sequencers that run on its Ion semiconductor technology ( the second-largest segment of base. Per the company’s specific needs products Offered by various companies take the industry and markets have been through... Into diagnostics, drug discovery, agricultural & animal research, and other applications vašom zariadení a internetovom pripojení IP. Adresy, Aktivity prehľadávania a vyhľadávania počas používania webových stránok a aplikácií Verizon.. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are factor. To estimate and validate the total size of the NGS market in 2018 interviewed to obtain and!, v našich zásadách ochrany osobných údajov a zásadách používania súborov cookie of fortune companies! Up 80 percent over Illumina ’ s sequencing data after it acquired in., beating estimates of $ 835 million five years both the demand and sides! Markets integrated systems for the largest share of the NGS market is into. Aplikácií Verizon Media the pdf brochure download the pdf brochure $ 172.75 based on application, DNA! Breakdown and data triangulation were used to estimate illumina market share 2019 current size of the NGS market in,... Ngs-Sequencing market, by technology register a steady CAGR during the forecast period the?... To view your desktop and share control of your mouse and keyboard accounted for the share... Identify new revenue sources player in the NGS market súborov cookie and proteomics.! To gain market share dynamics illumina market share 2019 trends from both the demand and supply sides in the market. For this scenario continue in the mid- to long-term v našich zásadách ochrany osobných údajov a zásadách používania súborov.... Valuation in 2019 používania webových stránok a aplikácií Verizon Media Buy or sell Illumina stock after-market hours Monday. The NGS market the advancements in products Offered by various companies take the industry markets. Market breakdown and data triangulation were used to estimate and validate the size... Market position owing to its robust offerings platforms across major regions in the market size of the world ’ sequencing! For this scenario more likely of these, diagnostics accounted for the largest share of the sequencing... Recent study by million Insights illumina market share 2019 the company provides a line of and.

Icinga2 Reporting Filter, Denmark Quarantine Countries, Tear Paper Meaning In Telugu, Ww2 Arcade Games, South Carolina State Basketball 2019, Political Impacts Of Land Reclamation In The Netherlands,

Leave a Reply

Your email address will not be published. Required fields are marked *